Correlation Between IShares Core and Teva Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both IShares Core and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Core and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Core SP and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on IShares Core and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Core with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Core and Teva Pharmaceutical.
Diversification Opportunities for IShares Core and Teva Pharmaceutical
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between IShares and Teva is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding iShares Core SP and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and IShares Core is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Core SP are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of IShares Core i.e., IShares Core and Teva Pharmaceutical go up and down completely randomly.
Pair Corralation between IShares Core and Teva Pharmaceutical
Considering the 90-day investment horizon IShares Core is expected to generate 8.84 times less return on investment than Teva Pharmaceutical. But when comparing it to its historical volatility, iShares Core SP is 2.33 times less risky than Teva Pharmaceutical. It trades about 0.04 of its potential returns per unit of risk. Teva Pharmaceutical Industries is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 307,500 in Teva Pharmaceutical Industries on January 24, 2024 and sell it today you would earn a total of 190,300 from holding Teva Pharmaceutical Industries or generate 61.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 80.65% |
Values | Daily Returns |
iShares Core SP vs. Teva Pharmaceutical Industries
Performance |
Timeline |
iShares Core SP |
Teva Pharmaceutical |
IShares Core and Teva Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with IShares Core and Teva Pharmaceutical
The main advantage of trading using opposite IShares Core and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Core position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.IShares Core vs. Vanguard Momentum Factor | IShares Core vs. Vanguard Value Factor | IShares Core vs. Vanguard SP Small Cap |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |